Aarhus Regenerative Orthopaedics Symposium (AROS): Regeneration in the ageing population

— The combination of modern interventional and pre-ventive medicine has led to an epidemic of ageing. While this phenomenon is a positive consequence of an improved lifestyle and achievements in a society, the longer life expectancy is often accompanied by decline in quality of life due to musculoskeletal pain and disability. The was by the need to address regenerative challenges in an ageing population by engaging clinicians, basic scientists, and engineers. In this position paper, we review our contemporary understanding of societal, patient-related, and basic science-related challenges

[1]  Yosuke Usui.  Knee , 2019, Nerve Blockade and Interventional Therapy.

[2]  M. Brittberg,et al.  Cartilage repair in the degenerative ageing knee: A narrative review and analysis , 2017 .

[3]  J. Farr,et al.  Cellular senescence in aging and osteoarthritis: Implications for cartilage repair , 2017 .

[4]  J. Urban,et al.  Biological challenges for regeneration of the degenerated disc using cellular therapies , 2016, Acta orthopaedica.

[5]  Teck Chuan Lim,et al.  Injectable biomaterials: a perspective on the next wave of injectable therapeutics , 2016, Biomedical materials.

[6]  J. Farr,et al.  Patients Scheduled for Chondrocyte Implantation Treatment with MACI Have Larger Defects than Those Enrolled in Clinical Trials , 2015, Cartilage.

[7]  A. Tucker,et al.  Predictors for 1-year mortality following hip fracture: a retrospective review of 465 consecutive patients , 2017, European Journal of Trauma and Emergency Surgery.

[8]  M. Lind,et al.  Autologous Dual-Tissue Transplantation for Osteochondral Repair , 2015, Cartilage.

[9]  N. Vrana,et al.  Cell Microenvironment Engineering and Monitoring for Tissue Engineering and Regenerative Medicine: The Recent Advances , 2014, BioMed research international.

[10]  J. Hui,et al.  Advances in Mesenchymal Stem Cell-based Strategies for Cartilage Repair and Regeneration , 2014, Stem Cell Reviews and Reports.

[11]  K. L. Wong,et al.  Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up. , 2013, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[12]  Yi Zeng.  Toward deeper research and better policy for healthy aging – using the unique data of Chinese longitudinal healthy longevity survey , 2012, China economic journal.

[13]  L. Engebretsen,et al.  Knee Cartilage Defect Patients Enrolled in Randomized Controlled Trials Are Not Representative of Patients in Orthopedic Practice , 2010, Cartilage.

[14]  E. Pei,et al.  Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation An Observational Cohort Study , 2010 .

[15]  B. Mandelbaum,et al.  Return to Sports Participation after Articular Cartilage Repair in the Knee , 2009, The American journal of sports medicine.

[16]  Laura Fratiglioni,et al.  Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. , 2008, American journal of public health.

[17]  Emily R. Hajjar,et al.  Polypharmacy in elderly patients. , 2007, The American journal of geriatric pharmacotherapy.

[18]  S. Glasson,et al.  The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.

[19]  K. Shelbourne,et al.  What I have learned about the ACL: utilizing a progressive rehabilitation scheme to achieve total knee symmetry after anterior cruciate ligament reconstruction , 2006, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[20]  C. Clar,et al.  Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. , 2005, Health technology assessment.

[21]  Joanne Greenhalgh,et al.  The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? , 2005, Social science & medicine.

[22]  E. Strauss.  Editorial comment. The aging epidemic. , 2004, Clinical orthopaedics and related research.

[23]  A. Poole,et al.  Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.

[24]  T. Takeda.  Senescence-accelerated mouse (SAM): a biogerontological resource in aging research , 1999, Neurobiology of Aging.

[25]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[26]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[27]  S. Mcphee,et al.  The Impact of Clinical Pharmacists' Consultations on Physicians' Geriatric Drug Prescribing: A Randomized Controlled Trial , 1992, Medical care.

[28]  F. Luyten,et al.  Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. , 1989, The Journal of biological chemistry.

[29]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[30]  A. Bendele,et al.  Spontaneous cartilage degeneration in guinea pigs. , 1988, Arthritis and rheumatism.

[31]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[32]  C. Dolea,et al.  World Health Organization , 1949, International Organization.